Brief: Guerbet Says OptiVantage Multi-Use Injector Is Now CE-Marked
Nov 23 (Reuters) - GUERBET SA GRBT.PA :
* OPTIVANTAGE MULTI-USE INJECTOR IS NOW CE-MARKED.
* OPTIVANTAGE®MULTI-USE WILL INITIALLY BE MARKETED IN EMEA
FROM
JANUARY 2019,
Source text: https://bit.ly/2TCYbKC
Further company coverage: GRBT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Guerbet SA
See all newsBrief: Guerbet Q1 Revenue At EUR 177.4 Mln
Guerbet Q1 revenue up 2.6% at CER on increased volumes in EMEA and Asia
Medical imaging firm Guerbet's 2025 revenue falls on lower sales activity in France
Brief: Guerbet Says FDA Approves Labeling Update For Guerbet's Elucirem Injection
France's Guerbet misses 2025 revenue estimates